Third Act Ventures

Third Act Ventures investment thesis

Featured Dec 1, 2025 Third Act Ventures selected as a Top Healthtech Seed Fund in 2025 Dec 1, 2025 Third Act Ventures was selected as one of the top Health Tech seed funds of 2025 Dec 1, 2025 Apr 15, 2025 Where Does AgeTech Investment Stand?: VCs Weigh Promise Against Payout Apr 15, 2025 At Medicarians 2025, MedCity News Editor-in-Chief Arundhati Parmar explored the state of AgeTech venture capital with three investors including Max Zamkow of Third Act Ventures. Apr 15, 2025 Aug 9, 2023 Mighty Health chosen for 2023 UnitedHealthcare Accelerator Aug 9, 2023 A fundamental priority for UnitedHealthcare has always been to be a leader in modernizing the health system and advancing new solutions for some of the most pressing challenges in health care. To continue playing a leading role in drivin

Third Act Ventures team (1)

Partners and principals at Third Act Ventures:

• Max Zamkow — sweet spot $50K

Third Act Ventures portfolio companies

Companies listed on Third Act Ventures's public materials include: Skip to Content, Criteria, Portfolio, Press, About, Agetech News, “Your Thesis Is Your Portfolio Page.”, hello@thirdact.vc.

Is Third Act Ventures a fit for your round?

Upload your pitch deck and see whether anyone at Third Act Ventures appears in your top matches.